Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedical Targets

Enantiocontrolled  Synthesis  of  Fluoro-Organic  Compounds:  Stereochemical  Challenges  and  Biomedical  Targets Struktur
CAS-Nr.
Englisch Name:
Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedical Targets
Synonyma:
Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedical Targets
CBNumber:
CB62094148
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedical Targets Eigenschaften

Sicherheit

Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedical Targets Chemische Eigenschaften,Einsatz,Produktion Methoden

Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedical Targets Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedical Targets Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 2)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Riedel-de Haen AG --
United States 6825 87
SIGMA-RBI --
Switzerland 6913 91

  • Enantiocontrolled Synthesis of Fluoro-Organic Compounds: Stereochemical Challenges and Biomedical Targets
Copyright 2019 © ChemicalBook. All rights reserved